Marv D. Shepherd, PhD
Two Studies Confirm Drug Importation Would Decimate The Canadian Drug Supply
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
[...]Shepherd M (2019) New pathways for U.S. importation threaten Canadian prescription drug supply. Canadian Health Policy Journal,
This research paper is an update to The Effect Of U.S. Pharmaceutical Drug Importation On The Canadian Pharmaceutical Supply, published in 2010.
[...]Drug Importation and the Deadly Challenge of Screening 275 Million Packages a Year
The Food and Drug Administration (FDA) in their report U.S. Food and Drug Administration and the International Mail Facilities (IMFs), describes the daunting job that Customs and Border Protection (CBP) faces when attempting to weed out counterfeit medications and packages containing illicit fentanyl. In 2017, IMFs received 275 million packages. Of these, 10,000 were screened by CBP, and of those 86% contained drugs. The investigation of a suspect package is incredibly time-consuming; an experienced FDA investigator might take as long as 20 minutes to process a package containing just on product.
[...]Drug Importation Isn’t Safe and It Doesn’t Make Economic Sense, Says PSM President
In this May 31, 2018 editorial for The Daily Caller, pharmacoeconomic expert Dr. Marv Shepherd explains the concrete reasons why the importation of drugs from other countries as a means to lowering prices in the U.S. is both unsafe and economically unsound.
[...]Partnership For Safe Medicines Urges Passage of the STOP Act to Increase Inspections for Dangerous Synthetic Opioids
Partnership For Safe Medicines Urges Passage of the STOP Act to Increase Inspections for Dangerous Synthetic Opioids Legislation will increase surveillance of primary smuggling route for fentanyl WASHINGTON (May 24, 2018) – The Partnership for Safe Medicines (PSM) today urged passage of the Synthetics Trafficking and Overdose Prevention Act of 2017 (S.372), also known as…
[...]Separating fact from fiction about drug importation at CNN’s recent Healthcare Town Hall
CNN’s September 25, 2017 Healthcare Town Hall was an opportunity for prominent senators to share important ideas about ways to improve Americans’ lives, but it also included some erroneous statements about drug importation. PSM’s Board President, Dr. Marv Shepherd, sent this letter on September 29 to clarify those issues.
[...]Making Canada America’s Medicine Cabinet Is Not The Solution To High Drug Prices
Marv Shepherd, President of Board of Directors for the Partnership for Safe Medicines, reexamined the possible effects on Canada’s drug supply should the U.S. legalize drug importation…
[...]Shepherd M (2018) U.S. Drug Importation: Impact on Canada’s Prescription Drug Supply. Health Econ Outcome Res Open Access 4: 146.
This research paper is an update to The Effect Of U.S. Pharmaceutical Drug Importation On The Canadian Pharmaceutical Supply, published in 2010.
[...]PSM Board President Dr. Marv Shepherd Explains the Dangers of Drug Importation
Dr. Shepherd was interviewed on a local Austin radio station and described for listeners the realities of the counterfeit medication economy, and the dangers U.S. citizens face from imported medication. After William Scully, owner of the unlicensed pharmaceutical importer Medical Device King/Pharmalogical, was convicted on charges relating to his drug importation business, Bill Swail, host…
[...]Leading Patient Advocacy Group Applauds Conviction of Illegal Drug Supply Operators
The Partnership for Safe Medicines released the following statement regarding the verdict of William Scully for operating an illegitimate drug supply company called Pharmalogical Inc., which conducts business as Medical Device King. The defendant sold more than $14 million worth of illegal products including misbranded cancer medicine, unapproved birth control devices, and other medical products…
[...]